Exact localization – with Mammography

In the diagnostic process, you need a solution for magnification and localization procedures, digital spot imaging, specimen radiography, galactography or image-guided stereotactic needle and core biopsies.

Biopsy in upright position
Stereotactic biopsy with MAMMOMAT Inspiration represents a highly integrated biopsy solution with a small foot-print.
The light-weighted biopsy unit (optional for MAMMOMAT Inspiration) just has to be slid upon the detector, and hardware configurations plus the user interface at the Acquisition Workstation (AWS) are automatically set for stereotactic biopsy. The workflow has been automated to a high degree, e.g. the tube is moved by remote control from the Acquisition Workstation.
Biopsies can be performed from any view (e.g. CC or MLO) and with either vertical or lateral needle guidance. The biopsy images are acquired with the same FFDM detector as screening and diagnostic images, and processed with the same Siemens image processing, OpView 2.
MAMMOMAT Inspiration

Biopsy in prone position
Or you may decide on a dedicated biopsy solution placing the patient in the more relaxing prone position. With our biopsy system MammoTest™, procedures are performed out of patients’ view. At the same time, however, you can maintain eye contact with your patients, and have full patient and lesion access during the procedure, thanks to MammoTest’s 360° range of gantry movement. In addition, the “Target on Scout” functionality gives you the flexibility to use the 0° image for position calculation, thus potentially reducing the number of image retakes. And its lateral arm makes MammoTest ideally suited for small breasts.
MammoTest

Reduced tissue overlap – with 3D Tomosynthesis
Tissue overlap is a limitation of both screen / film and digital mammography. You can eliminate this limitation with Breast Tomosynthesis: Several views of the breast are acquired from different viewing angles and the slice images are reconstructed into a 3D volume set, thus providing better specificity and sensitivity. The benefit of Breast Tomosynthesis for women is very clear: a faster diagnosis.
3D Breast Tomosynthesis

Excellent evaluation of malignant patterns – with Magnetic Resonance

Dense breast tissue and breast implants are a major challenge when imaging breast cancer tumors in the diagnostic process: this is where Magnetic Resonance come into play. The diagnostic procedure includes not only the visualization and sizing but also the characterization and evaluation of whole-body lymph nodes. For staging and diagnosis, Magnetic Resonance offers ideal solutions. 3D imaging of the breast provides excellent information of the lesion extent and shows the differences between normal and malignant tissue. All this helps to determine the lesions extent and hype.

We have complemented our MAGNETOM family with a dedicated MR breast scanner: MAGNETOM Espree – Pink, the next generation of breast MRI. Whether for diagnostics, during therapy or follow-up, the new system offers unmatched patient comfort with Pink Comfort, unique applications with Pink Applications, and an innovative workflow with Pink Workflow. In short: MAGNETOM Espree – Pink combines the open-bore design of MAGNETOM Espree and a wide range of applications dedicated to improve diagnostic confidence with the Sentinelle Vanguard for Siemens solution that offers exceptional breast imaging and biopsy capabilities. The workplaces are equipped with a great number of computer-aided tools such as syngo BreVis for effective breast reading including BIRADS reporting and syngo BreVis Biopsy for interventional procedure planning.
MAGNETOM Espree - Pink

Tim Technology
Our MAGNETOM systems with the standard syngo MR Breast Suite are ideal for imaging lesions in women with dense breasts and implant imaging: dedicated protocols and techniques are clearly visualize lesions and breast implants such as silicone or saline. In addition, they offer our unique Tim (Total imaging matrix) technology for pristine image quality. This means you'll have superior visualization, from details like small breast lesions to whole body screening. And, you'll obtain one of the highest signal-to-noise ratios with coverage from 5 mm up to 205 cm. With iPAT accelleration in all directions, Tim also delivers accelerated acquisition speed - while still offering the high spatial resolution needed for breast diagnosis.
Tim

syngo GRACE
Metabolic information can be gained with syngo GRACE, our application for quantitative MR breast spectroscopy. Having the ability to detect metabolic changes in tissue, it may provide additional confidence as a tool for the diagnosis of breast lesions. With choline acting as a biomarker, you can gain essential information on the biochemical composition of lesions.
This information is important to determine if lesions are malignant or not - to help reduce the patient risk of unnessary breast biopsies as well as enable an accurate assessment of the efficacy of the treatment such as chemotherapy.
syngo GRACE

syngo VIEWS
Our software solution syngo VIEWS provides both anatomical and functional information for exact tumor and lesion staging. By stimulating the water spins, it shows excellent fat suppression and provides 3D bilateral breast imaging in sub-milimeter range. You benefit from full coverage of both breasts and good lateral coverage up to the axilla region at both the highest temporal and highest spatial resolution. And combining syngo VIEWS with Parallel imaging's technique (syngo GRAPPA), you also get superb protocols for high-resolution breast scanning. Due to its isotropic voxel size, images can be easily reformatted in any desired slice orientation.
syngo VIEWS

Accurate body tumor staging – with Computed Tomography

When staging a tumor, it is important to determine the presence of additional tumors and potential malignancies throughout the body. For this, it is important to have outstanding image quality with high spatial resolution and optimum coverage.

SOMATOM® Definition AS, the world’s first Adaptive Scanner, is a fundamentally new way to use single-source CT, provides a new way to use single source CT. Imagine a CT scanner that truly adapts to your patients and your clinical questions – making it an expert in virtually any clinical field. Opening up new worlds of clinical and economic possibilities. Increasing the quality and efficiency of patient care. And thus making the SOMATOM Definition AS the ideal scanner for everyday tumor staging.
SOMATOM Definition AS

Our software syngo CT Oncology provides unrivaled diagnostic confidence for routine tumor staging – especially for the evaluation of tumors in typical locations such as in the lung, liver or lymph nodes. Dedicated autopilots automate tumor segmentation and measurement, enabling robust calculation of the tumor size, including besides the standards RECIST (1.0) and WHO the forward-looking volume evaluation of the tumor, and the total tumor burden. And by seamlessly integrating image fusion for hybrid imaging plus DICOM RT reporting, syngo CT Oncology uniquely offers a one-stop shop for high speed and maximum confidence in tumor staging as part of breast cancer care.
syngo CT Oncology

“The Adaptive Scanner, SOMATOM Definition AS, enables us to address any clinical question in any situation.”
Joseph Schoepf, MD, Department of Radiology, Medical University of South Carolina, Charleston, USA

Improved diagnostic accuracy – with Molecular Imaging

Particularly in dense breast tissue or implants, it is difficult to reliably stage primary tumors and differentiate benign from malignant breast lesions. Here, metabolic imaging with PET•CT is useful to characterize a breast mass. Our comprehensive suite of equipment for molecular imaging offers sophisticated clinical imaging as well as preclinical and biomarker solutions. Where other clinical procedures may have proven inconclusive, PET has been proven to be very useful in depicting metastases.

Data courtesy of the University of Tennessee, Knoxville, USA

Hybrid systems such as our Biograph™ for PET•CT combine the anatomical information provided by CT with the functional information and tumor metabolism obtained with PET, leading to an improvement in diagnostic confidence as well as therapeutic decision-making. Using the tracer 18F-FDG, PET•CT enables accurate staging of breast carcinoma by localizing axillary lymph node and distant metastases.
PET•CT Technological advancements such as HD•PET and ultraHD•PET provide high resolution across the entire field of view and high lesion contrast for enhanced delineation of small lymph nodal and distant metastases – for diagnostic confidence and staging accuracy.

Courtesy of the Beijing Hospital, Beijing, China

Our Symbia® S and Symbia E for SPECT, and the hybrid Symbia TruePoint™ SPECT•CT systems can improve the diagnosis and localization of skeletal metastases. Hybrid devices such as SPECT•CT and PET•CT can improve diagnostic accuracy and eliminate additional investigations, thereby substantially reducing the time needed for diagnoses, which may lead to cost savings and speed up appropriate therapy.
SPECT•CT

“What’s novel about Symbia TruePoint SPECT•CT is that you perform two exams in the same sitting – we can acquire the CT scan right after the SPECT and fuse the image. The result is more precise localization of the node. Here, we call it ‘SPECT-ACULAR-CT.’”
Homer Macapinlac, MD, Professor and Chairman of Nuclear Imaging, MD Anderson Cancer Center, Houston, Texas, USA